Business Description
Surrozen Inc
NAICS : 541714
SIC : 2833
ISIN : US86889P2083
Share Class Description:
SRZN: Ordinary SharesDescription
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 20.31 | |||||
| Equity-to-Asset | 0.12 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | -0.06 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -8.81 | |||||
| Beneish M-Score | 4.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -15.5 | |||||
| 3-Year EPS without NRI Growth Rate | -12.5 | |||||
| 3-Year FCF Growth Rate | -16.3 | |||||
| 3-Year Book Growth Rate | -3.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 42.26 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.12 | |||||
| 9-Day RSI | 69.25 | |||||
| 14-Day RSI | 62.63 | |||||
| 6-1 Month Momentum % | -14.03 | |||||
| 12-1 Month Momentum % | 35.07 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.4 | |||||
| Quick Ratio | 7.4 | |||||
| Cash Ratio | 5.07 | |||||
| Days Sales Outstanding | 150.13 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 4 | |||||
| Shareholder Yield % | 5.87 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -266.31 | |||||
| Net Margin % | -444.38 | |||||
| FCF Margin % | -284.27 | |||||
| ROE % | -177.28 | |||||
| ROA % | -96.67 | |||||
| ROIC % | -318.93 | |||||
| ROC (Joel Greenblatt) % | -478.94 | |||||
| ROCE % | -67.34 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.94 | |||||
| PB Ratio | 7 | |||||
| Price-to-Tangible-Book | 7.01 | |||||
| EV-to-EBIT | -0.38 | |||||
| EV-to-EBITDA | -0.41 | |||||
| EV-to-Revenue | 1.02 | |||||
| EV-to-FCF | -0.36 | |||||
| Price-to-Net-Current-Asset-Value | 13.41 | |||||
| Earnings Yield (Greenblatt) % | -263.16 | |||||
| FCF Yield % | -71.7 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:SRZN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Surrozen Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 10 | ||
| EPS (TTM) ($) | -17.04 | ||
| Beta | 1.06 | ||
| Volatility % | 94.7 | ||
| 14-Day RSI | 62.63 | ||
| 14-Day ATR ($) | 1.30342 | ||
| 20-Day SMA ($) | 10.04821 | ||
| 12-1 Month Momentum % | 35.07 | ||
| 52-Week Range ($) | 5.9999 - 16.19 | ||
| Shares Outstanding (Mil) | 3.25 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Surrozen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Surrozen Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Surrozen Inc Frequently Asked Questions
What is Surrozen Inc(SRZN)'s stock price today?
The current price of SRZN is $12.20. The 52 week high of SRZN is $16.19 and 52 week low is $6.00.
When is next earnings date of Surrozen Inc(SRZN)?
The next earnings date of Surrozen Inc(SRZN) is 2025-02-06 Est..
Does Surrozen Inc(SRZN) pay dividends? If so, how much?
Surrozen Inc(SRZN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers